DE69225387D1 - Mit Mittel zur Verminderung der Hautreizung ausgerüstetes iontophoretisches System - Google Patents

Mit Mittel zur Verminderung der Hautreizung ausgerüstetes iontophoretisches System

Info

Publication number
DE69225387D1
DE69225387D1 DE69225387T DE69225387T DE69225387D1 DE 69225387 D1 DE69225387 D1 DE 69225387D1 DE 69225387 T DE69225387 T DE 69225387T DE 69225387 T DE69225387 T DE 69225387T DE 69225387 D1 DE69225387 D1 DE 69225387D1
Authority
DE
Germany
Prior art keywords
skin irritation
system equipped
reducing skin
iontophoretic system
iontophoretic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69225387T
Other languages
English (en)
Other versions
DE69225387T2 (de
DE69225387T3 (de
Inventor
John L Haynes
Burton H Sage Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vyteris Inc
Original Assignee
Becton Dickinson and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27123163&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69225387(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/808,754 external-priority patent/US5246418A/en
Priority claimed from US07/848,217 external-priority patent/US5256137A/en
Application filed by Becton Dickinson and Co filed Critical Becton Dickinson and Co
Publication of DE69225387D1 publication Critical patent/DE69225387D1/de
Publication of DE69225387T2 publication Critical patent/DE69225387T2/de
Application granted granted Critical
Publication of DE69225387T3 publication Critical patent/DE69225387T3/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/044—Shape of the electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0448—Drug reservoir

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Electrotherapy Devices (AREA)
DE1992625387 1991-12-17 1992-12-09 Mit Mittel zur Verminderung der Hautreizung ausgerüstetes iontophoretisches System Expired - Fee Related DE69225387T3 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US808754 1977-06-22
US07/808,754 US5246418A (en) 1991-12-17 1991-12-17 Iontophresis system having features for reducing skin irritation
US07/848,217 US5256137A (en) 1992-03-10 1992-03-10 Biphasic power source for use in an iontophoretic drug delivery system
US848217 1992-03-10

Publications (3)

Publication Number Publication Date
DE69225387D1 true DE69225387D1 (de) 1998-06-10
DE69225387T2 DE69225387T2 (de) 1998-11-26
DE69225387T3 DE69225387T3 (de) 2007-04-12

Family

ID=27123163

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1992625387 Expired - Fee Related DE69225387T3 (de) 1991-12-17 1992-12-09 Mit Mittel zur Verminderung der Hautreizung ausgerüstetes iontophoretisches System

Country Status (5)

Country Link
EP (1) EP0547482B2 (de)
JP (1) JPH0761365B2 (de)
AU (1) AU655859B2 (de)
CA (1) CA2084734C (de)
DE (1) DE69225387T3 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2181742C (en) 1994-03-30 2005-06-14 Philip W. Ledger Reduction of skin irritation during electrotransport delivery
US5697896A (en) * 1994-12-08 1997-12-16 Alza Corporation Electrotransport delivery device
IE960312A1 (en) 1995-06-02 1996-12-11 Alza Corp An electrotransport delivery device with voltage boosting¹circuit
AU710793B2 (en) * 1995-06-07 1999-09-30 Alza Corporation Electrotransport agent delivery method and apparatus
US5983130A (en) * 1995-06-07 1999-11-09 Alza Corporation Electrotransport agent delivery method and apparatus
US6718201B1 (en) 1996-06-07 2004-04-06 Alza Corporation Electrotransport agent delivery method and apparatus
US6018679A (en) 1997-01-29 2000-01-25 Novartis Finance Corp. Iontophoretic transdermal delivery and control of adverse side-effects
FR2761892B1 (fr) * 1997-04-11 1999-07-02 Raoul Parienti Systeme d'application d'or aux tissus cutanes du visage
FR2766093B1 (fr) * 1997-07-15 1999-09-03 Lhd Lab Hygiene Dietetique Procede de commande d'un dispositif d'administration transdermique de medicament sous champ electrique
AU1997699A (en) * 1997-12-16 1999-07-05 Alza Corporation Regulator with artificial load to maintain regulated delivery
KR100245835B1 (ko) * 1998-02-10 2000-06-01 이양희 습포제
US6162460A (en) * 1998-03-10 2000-12-19 Lee; Yang-Hee Poultice
US6192270B1 (en) * 1998-08-14 2001-02-20 Genetronics, Inc. Apparatus and method for the delivery of drugs and genes into tissue
US6611706B2 (en) 1998-11-09 2003-08-26 Transpharma Ltd. Monopolar and bipolar current application for transdermal drug delivery and analyte extraction
US6148232A (en) * 1998-11-09 2000-11-14 Elecsys Ltd. Transdermal drug delivery and analyte extraction
US6597946B2 (en) 1998-11-09 2003-07-22 Transpharma Ltd. Electronic card for transdermal drug delivery and analyte extraction
US6708060B1 (en) 1998-11-09 2004-03-16 Transpharma Ltd. Handheld apparatus and method for transdermal drug delivery and analyte extraction
KR20010112420A (ko) * 1999-04-12 2001-12-20 나까도미 히로다카 이온토포레시스용 디바이스
EP1537893B1 (de) * 1999-04-14 2012-01-25 Medtronic Transneuronix, Inc. programmierbares Gastrostimulationsgerät
JP4199385B2 (ja) 1999-09-20 2008-12-17 久光製薬株式会社 イオントフォレーシスシステム
US7406351B2 (en) 2005-04-28 2008-07-29 Medtronic, Inc. Activity sensing for stimulator control
US7389147B2 (en) * 2005-04-29 2008-06-17 Medtronic, Inc. Therapy delivery mode selection
US20090204056A1 (en) * 2006-05-17 2009-08-13 Zvi Nitzan Constant current treatment device
WO2008004204A1 (en) * 2006-07-06 2008-01-10 University Of Limerick An electrical stimulation device for nerves or muscles
JP5383497B2 (ja) 2006-12-01 2014-01-08 Ｔｔｉ・エルビュー株式会社 装置、例として経皮送達装置に給電し且つ／又は当該装置を制御するシステム及び装置
JP5612474B2 (ja) 2007-10-17 2014-10-22 トランスファーマ メディカル リミテッド 溶出速度の検証
US8606366B2 (en) 2009-02-18 2013-12-10 Syneron Medical Ltd. Skin treatment apparatus for personal use and method for using same
US8958875B2 (en) 2010-02-03 2015-02-17 Medtronic, Inc. Stimulation mode switching based on tissue impedance stability
US9020589B2 (en) 2010-04-27 2015-04-28 Medtronic, Inc. Electrical stimulator with voltage mode emulation using regulated current
EP2656872B1 (de) 2010-12-22 2021-07-21 Teikoku Seiyaku Co., Ltd. Elektrodenpad für die iontophorese

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1603649A (de) * 1968-12-26 1971-05-10
US4141359A (en) * 1976-08-16 1979-02-27 University Of Utah Epidermal iontophoresis device
US4292968A (en) * 1979-11-26 1981-10-06 Sybron Corporation Electric supply for ion therapy
US4456012A (en) * 1982-02-22 1984-06-26 Medtronic, Inc. Iontophoretic and electrical tissue stimulation device
US4822334A (en) * 1986-12-04 1989-04-18 Robert Tapper Electrical dosimetry control system
US5047007A (en) * 1989-12-22 1991-09-10 Medtronic, Inc. Method and apparatus for pulsed iontophoretic drug delivery

Also Published As

Publication number Publication date
CA2084734C (en) 1998-12-01
AU3019992A (en) 1993-06-24
EP0547482B1 (de) 1998-05-06
EP0547482A1 (de) 1993-06-23
EP0547482B2 (de) 2006-08-30
AU655859B2 (en) 1995-01-12
DE69225387T2 (de) 1998-11-26
DE69225387T3 (de) 2007-04-12
JPH05245214A (ja) 1993-09-24
JPH0761365B2 (ja) 1995-07-05
CA2084734A1 (en) 1993-06-18

Similar Documents

Publication Publication Date Title
DE69225387T2 (de) Mit Mittel zur Verminderung der Hautreizung ausgerüstetes iontophoretisches System
GB9115276D0 (en) Skin treatment system
DE69202739T2 (de) Gemischtes Alkylmethylsiloxane zur Hautpflege.
DE59307855D1 (de) Defibrillierungssystem
DE3678184D1 (de) Ueberschalltherapiesystem.
DE69232410T2 (de) Extern kontrolliertes system zur anrufbehandlung
DE59209886D1 (de) Implantierbares Defibrillationssystem
DE59308186D1 (de) Implantierbares defibrillationssystem
DK101390A (da) Bogie til hurtigkoerende skinnekoeretoejer
DE69309698T2 (de) Hautbehandlung mit adhäsionsverstärkenden eigenschaften
BR9305642A (pt) Implantes subcutàneos baseados em derivados de nomegestrol
KR950700707A (ko) 치과용 치료시스템
DE69202707D1 (de) Alkylmethylsiloxane zur Hautpflege.
GB2257632B (en) Skin treatment device
GB8723826D0 (en) Topical application for skin care
GB9222260D0 (en) Skin treatment
DE69207898D1 (de) Wirkstoff zur hautbehandlung bei tieren
DK166370C (da) Bogielignende understel til skinnekoeretoejer
GB9218773D0 (en) Skin treatment
DE9312888U1 (de) Hautbestrahlungsgerät
ITMI922518A1 (it) Medicazione per patologie cutanee
NO923108D0 (no) Hudpleie-behandling
DE9413599U1 (de) Mittel zur topischen Hautbehandlung
SE8502549D0 (sv) Hudbehandlingsmedel
ES288496Y (es) Aparato para tratamientos cutaneos y de estetica

Legal Events

Date Code Title Description
8363 Opposition against the patent
8327 Change in the person/name/address of the patent owner

Owner name: DRUG DELIVERY TECHNOLOGIES, INC., FAIR LAWN, N.J.,

8327 Change in the person/name/address of the patent owner

Owner name: VYTERIS, INC. (N.D.GES.D. STAATES DELAWARE), FAIR

8366 Restricted maintained after opposition proceedings
8339 Ceased/non-payment of the annual fee